Congress Asset Management CO Pacira Bio Sciences, Inc. Transaction History

Congress Asset Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$25.5 - $31.51 $26,035 - $32,171	-1,021 Reduced 1.15%	87,941 $2.52 Million
Q1 2024 Apr 11, 2024	BUY	$27.7 - $35.48 $30,331 - $38,850	1,095 Added 1.25%	88,962 $2.6 Million
Q4 2023 Mar 04, 2024	BUY	$26.32 - $34.31 $8,290 - $10,807	315 Added 0.36%	87,867 $2.96 Million
Q3 2023 Nov 01, 2023	BUY	$30.68 - $40.09 $3,589 - $4,690	117 Added 0.13%	87,552 $2.69 Million
Q2 2023 Jul 27, 2023	BUY	$36.12 - $47.5 $39,623 - $52,107	1,097 Added 1.27%	87,435 $3.5 Million
Q1 2023 Apr 21, 2023	BUY	$35.53 - $43.38 $304,278 - $371,506	8,564 Added 11.01%	86,338 $3.52 Million
Q4 2022 Jan 18, 2023	BUY	$38.19 - $57.45 $21,921 - $32,976	574 Added 0.74%	77,774 $0
Q3 2022 Nov 08, 2022	BUY	$51.24 - $58.89 $1.82 Million - $2.09 Million	35,474 Added 85.02%	77,200 $4.11 Million
Q2 2022 Aug 02, 2022	BUY	$51.49 - $81.64 $2.15 Million - $3.41 Million	41,726 New	41,726 $2.43 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

Stay updated on Congress Asset Management CO with notifications on news.